The processes of receptor internalization and recycling have been well-documented for receptors for hormones, growth factors, lysosomal enzymes, and cel lular substrates. Evidence also exists that these pro cesses also occur for f)-adrenergic, muscarinic cholin ergic, and a-opiate receptors in frog erythrocytes or cul tured nervous tissue. In this study, evidence is presented that agonist-mediated receptor internalization and recy cling occurs at the dopamine receptor in rat corpus striatum. First, the in vivo binding of the dopamine an tagonist [3H]spiperone was increased by both electrical stimulation and pharmacologically induced increases of dopamine release. Conversely, depletion of dopamine with reserpine decreased in vivo [3H]spiperone binding, but the same reserpine treatment did not alter its in vitro binding. Second, the rate of dissociation of [3H]spiperone from microsomal membranes prepared from rat striatum
The ability of neurons to modulate the number and function of receptors at the synapse is impor tant for the regulation of neuronal activity in re sponse to varied afferent stimulation. The results of pharmacological and lesion studies suggest that mechanisms exist to regulate receptor number in order to preserve homeostasis. Denervation or chronic receptor blockade with antagonist drugs in creases receptor number. Conversely, chronic re ceptor stimulation with either agonist drugs or neu rotransmitter-releasing drugs results in reduced re ceptor number. The total number of receptors changes very slowly, however, in response to chronic alterations in ligand concentration. This following in vivo binding was fivefold slower than its dis sociation following in vitro equilibrium binding. Mild de tergent treatment, employed to disrupt endocytic vesicle membranes, increased the rate of dissociation of in vivo bound [3H] spiperone from microsomal membranes to values not significantly different from its in vitro bound dissociation rate. Third, treatment of rats with chloro quine, a drug that prevents receptor recycling but not in ternalization, prior to [3H]spiperone injection resulted in a selective increase of in vivo [3H] spiperone binding in the light microsome membranes. The existence of mech anisms that rapidly alter the number of neurotransmitter receptors at synapses provides dynamic regulation of re ceptors in response to varied acute stimulation states. Key Words: In vivo binding-Spiperone-Receptor-me diated endocytosis-Dopamine receptor.
suggests that these changes in receptor number are the result of altered biosynthesis and/or degrada tion of the receptors. The slow response of neuro transmitter receptor number to alterations in stimu lation, as well as the slow net turnover rate of these receptors, has encouraged the general notion that the postsynaptic membrane is static with regard to insertion and removal of receptors.
However, the number of receptors at the synapse may be altered rapidly not by altering the total number of receptors, but by altering the distribu tion of receptors between the cell surface and intra cellular pools. Rapid receptor internalization has been demonstrated for a variety of nonneuronal re ceptors, such as those for low density lipoprotein, insulin, transferrin, asialoglycoprotein, and epi dermal growth factor (for review, see Goldstein et ai. , 1979; Wileman et ai. , 1985) . Recently, evidence has emerged that receptors for neurotransmitters redistribute between the cell surface and intracel-lular pools. For example, incubation of frog eryth rocytes and human astrocytoma cells with the (3-ad renergic agonist, isoproterenol, results in rapid functional desensitization accompanied by a shift of 50%-60% of surface (3-adrenergic receptors to an intracellular pool with no decrease in the total number of receptors (Chuang and Costa, 1979; Harden et aI., 1980; Stadel et aJ., 1983; lnsel et aI., 1983) . Removal of the agonist results in restoration of both function and surface receptors, whereas continued incubation of the cells with agonist re sults in a decrease in the total number of (3-adren ergic receptors in the cells (Doss et aI., 1981) . Sim ilar evidence for rapid functional desensitization and receptor redistribution in response to agonist treatment also exists for muscarinic cholinergic re ceptors in several cell types (Galper et aI., 1982; Maloteaux et aI., 1983a; Feigenbaum and EI-Faka hany, 1984) and for �-opiate receptors in neuroblas toma x glioma hybrid cells (Chang et aI., 1982; Blanchard et aI., 1983; Law et aI., 1982 Law et aI., , 1984 . These findings suggest that there are mechanisms not only for slow, long-term changes in receptor number in response to chronic changes in stimula tion, but also for rapid, short-term changes in re ceptor distribution in response to acute changes in stimulation.
While rapid internalization and recycling of re ceptors from the synaptic membrane to an internal pool has not been thus far demonstrated in the brain, there is circumstantial evidence that these processes do occur in brain. Many neurotrans mitter receptors have been measured in microsomal membranes (Luabeya et aI., 1986) , even in studies demonstrating little contamination with synaptic plasma membranes (Roth et aI., 1981 (Roth et aI., , 1982 Roth and Coscia, 1984) . Furthermore, Roth and Coscia (1984) demonstrated that guanine nucleotides al tered the affinity of synaptic plasma membrane opiate receptors from rat brain, but did not alter the affinity of opiate receptors in microsomal mem branes. These findings parallel those in which sur face (3-adrenergic receptors in frog erythrocytes, but not internalized receptors, were sensitive to added guanine nucleotides (Chuang et aI., 1980; Harden et aI., 1980) . The processes of agonist-mediated receptor in ternalization and recycling can, in addition, help explain discrepancies between the binding of re ceptor ligands in vivo in brain as compared to their binding to membrane preparations in vitro. First, the in vivo clearance half-lives of several ligands are far longer than that predicted by their in vitro dissociation rates. For example, the in vitro disso ciation half-life of PH]spiperone is about 15 min J Cereb Blood Flow Metab, Vol. 8, No.3, 1988 (Leysen et aI., 1978) , whereas its in vivo clearance half-life is greater than 16 h (Laduron et aI., 1978) . Perry et ai. (1980) noted a similar discrepancy be tween the in vivo and in vitro binding of the opiate antagonist diprenorphine. They suggested that this may be due to a diffusion barrier at the synapse. In addition, it has been suggested that rebinding of the ligand to the receptor due to the diffusion barrier occurs in vivo but not in vitro (Frost, 1982) . Since the synaptic junction remains intact in many mem brane preparations, it is not clear why the diffusion barrier is not also present in vitro. Following re ceptor internalization, however, the receptor bound ligand would face the lumen of the endocytic vesicle or endosome. In the acidic environment of the endosome, weak bases such as [3H]spiperone exist largely in the charged form, which would be expected to have a limited diffusion rate across the vesicle membrane. The endosome would provide a diffusion barrier only in vivo because both receptor endocytosis and endosome acidification are en ergy-dependent processes (for review, see Wileman et aI., 1985) .
Another discrepancy between the in vivo and in vitro binding of pH]spiperone is that dopamine competes with [3H]spiperone binding in vitro, whereas the dopamine-releasing drugs, d-amphet amine and bupropion, increase the in vivo accumu lation of [3H]spiperone and [3H]pimozide (Baudry et aI., 1977; Niehoff et aI., 1979; Saelens et aI., 1980; Ellison and Morris, 1981; Bischoff et aI., 1984) . These apparently inconsistent findings might be explained, however, by postulating increased trapping of [3H]spiperone in endosomes in vivo due to an increased rate of receptor internalization re sulting from increased dopamine release.
We now present three lines of evidence that ago nist-mediated receptor internalization and recycling occurs at the dopamine (02) receptor in rat corpus striatum. Voigtlander and Moore, 1971; Wightman et aI., 1978) . The rat was then sacrificed by decapitation, and the brain was rapidly removed, frozen in powdered dry ice, and then processed for autoradiographic studies. Twenty micrometer coronal sections were cut in a cryostat and mounted on glass cover slips. Dried sections were apposed to LKB tritium-sensitive Ultrofilm in a spring-loaded x-ray cassette for 6-8 weeks, together with tritium tissue standards. Following development of the film, the optical densities of the lateral striata and the standards were measured using a Sargent-Welch "Den sichron" densitometer. The concentration of tritium in striatal tissue was calculated from the calibration curve generated from the standards. Student's t test was used to test for the statistical significance of differences be tween the stimulated and unstimulated sides.
METHODS

Cerebral blood flow
Local cerebral blood flow was measured using 4-iodo(N -methyl-[14C] antipyrine (Amersham, 51 mCi/ mmo!) according to the quantitative autoradiographic method of Sakurada et al. (1978) . Electrodes were stereo taxically implanted in substantia nigra pars compacta of rats (n = 4), as described above at least 1 week prior to the experiment. After 3 h recovery from anesthesia for implantation of venous and arterial cannulae, the elec trical stimulation (parameters as above) was begun. Ten minutes later, the [I4CJiodoantipyrine (50 /-LCi in 0.4 ml saline) was infused through the venous cannula. The electrical stimulation occurred throughout the infusion until the rat was killed by decapitation after 35 to 45 s of infusion. The striatum contralateral to the stimulation served as a control. Statistical differences in left/right blood flow ratios were measured using the Student's t test.
Effect of pharmacological agents on in vivo [3H]spiperone binding
In some rats (n = 3), the dopamine agonist apomor phine (5 or 20 mg/kg, i.p.) was administered 1 h prior to the intravenous injection of [3H]spiperone (500 /-LCi/kg). In other rats (n = 3), dopamine was depleted with reser pine (5 mg/kg, s.c.) (Carlsson et aI., 1957; Kirshner et al. 1963 ) administered 24 h prior to PH]spiperone injection (250 /-LCi/kg). All rats were decapitated 2 h after the injec tion of PH]spiperone, and the brains were prepared for autoradiography as described above or for liquid scintil lation counting. For the latter, corpus striatum and cere bellum were rapidly dissected and homogenized in 10 vol ethanol, and aliquots were counted in 10 ml Liquiscint (National Diagnostics).
Effect of medial forebrain bundle lesion on in vivo [3H]spiperone binding 6-Hydroxydopamine (5 /-Lg in 5 /-Ll saline containing 2% ascorbic acid) was infused at a rate of 1 /-LlImin through a Hamilton syringe stereotaxically placed in the medial forebrain bundle. Ten days following the infusion, d-am phetamine (2 mg/kg i.p.) was administered to test for ade quate nigrostriatal lesions, which was indicated by ipsi lateral turning in response to d-amphetamine (n = 4) (Ungerstedt, 1971) . Rats that passed this test were in jected intravenously with PH]spiperone 2 days later. They were decapitated 2 h following [3H]spiperone ad ministration, and their striata were rapidly removed, ho mogenized in 10 vol ethanol, and counted in 10 ml Liquiscinto In some animals (n = 3), a portion of each striatum was assayed for dopamine content according to the method described by Dudley et al. (1981) .
Effect of pharmacological agents, time after injection, and chloroquine on the subcellular distribution of in vivo and in vitro [3H]spiperone binding
[3H]Spiperone (250 /-LCi/kg) was injected intravenously either in the tail vein or through a cannula that was im planted as previously described in the femoral vein of the rat. Reserpine (5 mg/kg, s.c.) was administered to one group of rats 24 h prior to [3H]spiperone injection. d-Am phetamine (5 or 20 mg/kg, i.p.) was administered to a second group immediately before [3H]spiperone infusion. Chloroquine (10 mg/kg, i.p.) was administered to a third group of rats 2 h prior to [3H]spiperone injection. Rats were decapitated at I h (d-amphetamine and reserpine treated) or 2 h (chloroquine treated) following the [3H]spiperone injection. The brains were rapidly re moved, and striata were dissected and placed on ice. For corresponding in vitro binding experiments, untreated or reserpine pretreated (as above) rats were killed by decap itation, and the brains were rapidly removed. Several striata were dissected and placed on ice. Subcellular frac tionation was then performed.
Fractionation procedures
Three subcellular fractionation procedures were used. The first method was performed as described by Leysen et al. (1981) . Four fractions were produced: PI (nuclear pellet), P2 (mitochondria, lysosomes, synaptosomes), P3 (microsomes), and S (supernatant). The second fraction ation method was performed as described by Laduron (1977) . Five fractions were produced: N (nuclear pellet), M (mitochondria, synaptasomes), L (lysosomes), P (mi crosomes), and S (supernatant). The third fractionation procedure was performed as described by Roth and Co scia (1984) . Five fractions produced by this procedure were studied: synaptic plasma membranes, light micro somes, lysosomes, mitochondria, and nuclear pellet. Protein concentration was measured according to the method described by Lowry et al. (1951) .
For in vivo binding studies, the fractions were sus pended in 50 mM Tris-HCI buffer (pH 7.4) and aliquots were counted in 10 ml Liquiscint. For in vitro binding studies, [3H]spiperone binding was measured in P2 and P3 fractions according to the method described by Leysen et al. (1981) .
Data analysis of fractionation studies
Analysis of variance was used to detect changes in each of the subcellular fractions with either drug treat ment or survival time following PH]spiperone injection. When a statistically significant change was detected, Dunnett's test was used to test for significant differences between individual time points for a given fraction.
Effect of detergent on dissociation rate of in vitro and in vivo PH]spiperone binding
For in vitro studies, untreated rats were decapitated, and striata were rapidly dissected. Tissue was fraction ated according to the five-fraction scheme described above, and microsomal membranes were prepared for in cubation according to the method described by Leysen et al. (1981) . Membranes were suspended in 20 vol 50 mM Tr is-HCI buffer (pH = 7.7 at 37°C). This suspension was diluted 40-fold in 50 mM Tr is-HCl buffer (pH = 7.6 at 37°C) that was 120 mM NaCI, 5 mM KCI, 2 mM CaCI 2 , 1 mM MgClz, and 0.1 % ascorbic acid (w/v). Five milliliter tissue suspension was added to 0.5 ml buffer containing PH]spiperone, forming a final concentration of 0.2 nM PH]spiperone. ( + )Butaclamol (1 fLM) was also present in studies measuring nonspecific binding. In one experi ment, in vitro equilibrium binding was measured as de scribed by Leysen et al. (1981) in the presence of in creasing concentrations of CHAPS detergent (0.01 %-0.3% w/v, Sigma). For dissociation rate experiments, following 15 min incubation at 37°C, ( + )butaclamol (250 fLI, 22 fLM) was added, and the tubes were returned to incubate at 37°C. In three experiments, the incubation buffer contained 0.05% w/v CHAPS (3-[(3-chol amidopropyl)dimethylammonio] I-propanesulfonate) de tergent. At 0, 1, 5, 15, and 30 min after the ( + )butaclamol was added, the samples were filtered over GF/B filters and washed three times with 5 ml ice-cold buffer. Filters were then counted in 10 ml Liquiscint.
For in vivo studies, [3H]spiperone was injected intrave nously (250 fLCi/kg), and rats were decapitated 12 h later. The striata were dissected, and the membranes were pre pared in the same way as for the in vitro studies. After dilution in Tris buffer either with or without 0.05% CHAPS detergent, the suspensions were incubated at 37°C for 0, 1, 5, 15, or 30 min and were then filtered as described above. Filters were placed in 10 ml Liquiscint for liquid scintillation counting. The X 2 test was used to test for significant differences between dissociation with and without 0.05% CHAPS.
RESULTS
Effect of nigrostriatal electrical stimulation on in vivo [3H]spiperone binding and blood flow
Unilateral electrical stimulation of the substantia nigra produced contraversive turning. Circling sub sided to varying degrees over the course of the ex periment. In several animals, contraversive turning was present early after injection of [3H]spiperone but only contralateral body positioning was present by the end of the experiment.
The stimulation produced increased [3H]spip erone uptake in lateral striatum ipsilateral to the stimulation (Fig. 1) , and the increase was greatest in animals displaying the most robust circling. This increase in [3H]spiperone uptake appeared as a crescent-shaped region of increased binding in the lateral striatum. Densitometry revealed a mean 30% increase in [3H]spiperone concentration on the side ipsilateral to the stimulation (2166 dpm/mg tissue ± 149 vs. 1664 dpm/mg tissue ± 83, p < 0.01).
In contrast to the increased striatal uptake of [3H]spiperone it produced, unilateral electrical stimulation of the substantia nigra did not produce an asymmetry in striatal blood flow as indicated by [14C]iodoantipyrine uptake (Fig. 2a) . However, sev- eral other extrapyramidal motor structures did show increased [14C]iodoantipyrine uptake. These include substantia nigra at the site of the stimula tion (Fig. 2d) , the subthalamic nucleus (Fig. 2c) , and the globus pallidus (Fig. 2b) . In addition, blood flow asymmetries in frontoparietal and temporal medial cortex were also apparent. Thus, while ce rebral blood flow was not discernibly altered in the striatum by nigrostriatal stimulation, other struc tures displayed unilateral increases.
Effect of pharmacological agents and medial forebrain bundle lesion on in vivo [3H]spiperone binding
Pretreatment with large doses (5 or 20 mg/kg, i. p. ) of the dopamine agonist, apomorphine, altered the topography of in vivo [3H]spiperone accumula tion in striatum (Fig. 3) . Bilateral crescents of [3H]spiperone binding in lateral striatum were iden tical to that seen unilaterally with nigrostriatal elec trical stimulation.
In contrast, pretreatment of rats with the dopa mine depleting drug, reserpine, resulted in a large decrease in [3H]spiperone accumulation in striatum (p < 0.001) but not in cerebellum, a 2 h postinjec tion (Fig. 4) . Dopamine was also depleted unilater ally by Iesioning the medial forebrain bundle with 6-hydroxydopamine ( (Fig. 5) . At 0. 1 % CHAP S, there is a 24% increase over binding in the absence of CHAPS. At higher CHAPS concentrations, binding decreases.
A concentration of 0.05% CHAPS was chosen for the dissociation rate studies because it was the highest concentration of detergent that could be used without loss of the majority of binding. This concentration of CHAPS did not significantly alter the rate of dissociation of [3H]spiperone from mi crosomal membranes in which [3H]spiperone was bound in vitro (Fig. 6) . In contrast, the dissociation rate of in vivo [3H]spiperone binding was signifi cantly increased by 0.05% CHAPS, as shown in 11.02 ± 1.17
Published value for dopamine content in adult rat striatum-11.9 ± 1.8 .... g/g tissue (Felice et aI., 1978) .
Effect of time after injection and pharmacological agents on the subcellular distribution of PH]spiperone binding
The first fractionation studies performed were designed to examine the subcellular localization of the increase of [3H]spiperone binding produced by d-amphetamine and the decrease produced by re serpine in in vivo studies. As shown in Fig. 9 The next group of fractionation experiments was designed to determine the time course of [3H]spip erone accumulation in the various fractions. These experiments were performed with the N, M, L, P, S fractionation procedure. The accumulation of [3H]spiperone was remarkably stable over a period of 1 to 12 h after injection in all fractions, as seen in Fig. 10 . There appears to be a relationship, how ever, between the decrease in the L fraction seen at 4 and 12 h and the increase in the supernatant.
The administration of 1 mg/kg unlabeled spip erone after 1 h of accumulation of a tracer dose of [3H]spiperone resulted in a time-dependent de crease in the M, L, and P fractions and a time-de pendent increase in the supernatant, as seen in Fig.  11 . The [3H]spiperone recovered in the P fraction decreased at 2 h and did not decrease further at 4 h. In contrast, the percent in the L fraction did not decrease at 2 h, but decreased at 4 h. These de creases in the P and L fractions were reflected by increases in the supernatant. The next group of fractionation experiments was designed to re-examine the question of the accumu lation of [3H]spiperone in subcellular fractions with time. In these experiments, more highly purified fractions were obtained using the Roth fraction ation scheme and earlier times were examined. In these experiments, more dramatic increases with time were as seen in Fig. 12 . Again, however, the increase was apparent in all fractions.
In an attempt to enhance the light microsomal en richment of [3H]spiperone, rats were pretreated with chloroquine. Two hours pretreatment with chloroquine produced a statistically significant in crease (p < 0.01) in the [3H]spiperone accumulated in vivo in the light microsomes at 2 h following [3H]spiperone injection, as shown in Fig. 13 . When data were corrected for protein content of the frac tions, the increase obtained in the light microsomes was 30% of control or a 67% increase in enrichment over the first supernatant. In each paired (control vs. chloroquine) experiment, however, the protein 
DISCUSSION
Studies with drugs that increase dopamine re lease and uptake have suggested that dopamine fa cilitates the in vivo binding of dopamine antagonist drugs (Baudry et aI. , 1977; Niehoff et aI. , 1979;  , 1984) . In contrast, dopamine competes with dopamine antagonists in in vitro binding assays (Creese, 1982) . In the present studies, we also found that increasing dopamine release in striatum by electrically stimulating the substantia nigra increased the in vivo binding of [3H]spiperone in a crescent-shaped region in the lateral corpus striatum. Furthermore, pretreatment with the do pamine agonist, apomorphine, resulted in the same pattern of in vivo [3H]spiperone binding in lateral striatum.
On the other hand, following depletion of dopa mine with reserpine, the selective accumulation of [3H]spiperone in striatum in vivo was largely elimi nated, while its in vitro binding was unaltered. De Jesus et al. (1986) recently reported no change in in vivo [3H]spiperone accumulation in mouse striatum with reserpine pretreatment. This group, however, used half the reserpine dose per kg body weight used in this study. Niehoff et al. (1979) similarly re ported no change in [3H]spiperone accumulation in mouse striatum with the lower dose, but a 25% de crease in striatal accumulation when that dose was administered twice. In summary, increasing dopa- (Neve et ai., 1982) , or no change (Bennett and Wooten, 1986) . This suggests that in the case of lesions, degradative changes possibly including changes in capillary permeability, gliosis, and mac rophage infiltration may affect [3H]spiperone accu mulation. In fact, it has been reported that glia con tain [3H]spiperone binding sites that are seroto nergic in character (Severson et ai., 1983) , and that lymphocytes accumulate [3H]spiperone by a nonre ceptor mechanism (Maloteaux et ai. , 1983b) . One possible explanation for the dopamine-de pendent binding of [3H] spiperone that occurs in vivo but not in vitro is that dopamine regulates blood flow to the striatum and thereby regulates the delivery of [3H]spiperone to the tissue in vivo. In agreement with this notion, apomorphine has been previously shown to increase blood flow in lateral striatum (Ingvar et ai., 1983) . Electrical stimulation of the substantia nigra in the present study, how ever, did not produce increases in striatal blood flow. (Bennett and Wooten, 1986 An alternative explanation of these data is that the in vivo [3H]spiperone-receptor complex in volves an accessory membrane binding site or is re cessed into the membrane, making the complex more stable and hence the dissociation rate slower. Mahan et ai. (1985) have suggested, for example, that agonist-induced desensitization results not from receptor internalization, but from an altered membrane location of the receptor without internal ization.
The results of the present subcellular fraction ation experiments demonstrated parallel increases and decreases of [3H]spiperone binding in the frac tion containing synaptic plasma membranes with the fraction containing endosomes following manip ulations of dopamine content in striatum and with survival time following [3H]spiperone administra tion. These results suggest either that PH]spip erone is not accumulating in striatum via agonist mediated endocytosis or that [3H]spiperone to gether with the receptors rapidly cycles between the synaptic plasma membrane and the endosome, resulting in a steady state condition between the two compartments.
In order to test whether PH]spiperone was recy cling with the receptor between the synaptic plasma membrane and the endosomes, chloroquine was administered. Chloroquine has been shown to inhibit receptor recycling to the cell surface but not receptor internalization at receptors for insulin, ly sosomal enzymes, and asialoglycoproteins (Gon zalez- Noriega et aI., 1980; Posner et aI. , 1982; Prin gault et aI. , 1985; Schwartz et aI. , 1984; Tietze et aI. , 1980; Van Leuven et al. , 1980) . While the mech anism of this action is not known, chloroquine and other weak bases are known to accumulate in acidic intracellular compartments, thereby raising the intravesicular pH. It is presumed that this pH change results in the disruption of endosome func tion. When rats were pretreated with chloroquine, a selective enrichment of [3H]spiperone in the light microsomal fraction was demonstrated.
In summary, three lines of evidence presented here support agonist-mediated receptor internaliza tion as a mechanism regulating the in vivo binding of [3H]spiperone. First, the in vivo accumulation of [3H]spiperone in striatum occurred by a dopamine dependent process. Second, mild detergent treat ment to lyse endosomes revealed cryptic binding sites in vitro and increased the rate of dissociation of in vivo [3H]spiperone binding to its in vitro dis sociation rate. Third, in the absence of chloroquine treatment, parallel increases and decreases of [3H]spiperone binding occurred in the synaptic plasma membranes and light microsomes. Pretreat ment with chloroquine, however, resulted in a se lective increase of PH]spiperone binding in the light microsomes. Considered in concert, these data provide strong evidence that [3H]spiperone is internalized and recycled with the dopamine re ceptor. There is, in fact, a report that the dopamine antagonist, haloperidol, labels the luminal surface of intracellular vesicles in anterior pituitary cells (Goldsmith et aI. , 1979) . A model of agonist-in duced internalization of the receptor-ligand com plex is presented in Fig. 14. The mechanism of receptor internalization may explain some of the inconsistencies in the in vitro binding literature. Different membrane preparation protocols used for binding experiments can pro duce different results when receptors occur in membrane compartments with different densities. For example, binding in whole homogenate would detect no decrease in the number of receptors fol lowing receptor internalization, while a 40,000 x g centrifugation step would detect a decrease in the number of receptors. Harden (1983) has suggested, further, that receptor internalization might also ex plain the shallow displacement of antagonist binding by agonists. In general, agonists are much more hydrophilic than antagonists and would there fore have difficulty in penetrating the endosomal membrane. He has suggested that the low agonist affinity population of receptors is not simply due to uncoupling from the nucleotide binding protein, but also due to internalization of the receptor.
More important than the implications of this mechanism for interpreting in vitro ligand binding studies is the recognition that rapid receptor inter nalization and recycling occurs at dopamine re ceptors in the brain. Such an agonist-induced shift in receptor membrane compartments provides an exquisitely sensitive mechanism for regulation of neuronal activity in response to stimulation. In ad dition, the trapping of neuroleptic drugs in this cycle may explain the continued therapeutic effi cacy of these drugs for weeks after the drug can no longer be measured in plasma.
